COYA
Coya Therapeutics, Inc.
There isn't enough reported data to score COYA yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
COYA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
COYA's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
COYA PE Valuation
COYA has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
COYA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect COYA's revenue to grow, with its earnings and profitability holding steady.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
COYA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.39 | -$0.28 |
| Q2 2026 | -$1.07 | +$0.17 |
| Q1 2026 | -$1.15 | -$0.08 |
| Q4 2025 | -$1.27 | -$0.29 |
| Q3 2025 | -$1.11 | -$0.45 |
| Q2 2025 | -$1.24 | -$0.50 |
| Q1 2025 | -$1.07 | -$0.21 |
| Q4 2024 | -$0.98 | -$0.19 |
COYA is still losing money, but less than at its worst: $1.39 per share over the past year, against $1.64 at its worst in early 2023.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over COYA on earnings, with more consistent year-over-year improvement.
COYA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $234.1K | -93% |
| Q2 2026 | $243.7K | +49% |
| Q1 2026 | $251.1K | -2.6% |
| Q4 2025 | $4M | +202769% |
| Q2 2025 | $163.6K | -95% |
| Q1 2025 | $257.9K | +103% |
COYA's revenue is growing: $234,134 last quarter, down 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4676% | -4608 points |
| Q2 2026 | -2891% | +1029 points |
| Q1 2026 | -3042% | -65 points |
| Q4 2025 | -152% | +208879 points |
| Q3 2025 | -68% | N/A |
| Q2 2025 | -3920% | -3826 points |
| Q1 2025 | -2977% | +1346 points |
| Q4 2024 | -209032% | N/A |
COYA's operating margin was −4676% last quarter, down 4608 points from the same quarter a year ago, near the bottom of its range since 2024.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over COYA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over COYA on profitability, with a higher operating margin.
COYA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.2M | -$6.1M |
| Q2 2026 | -$7.4M | -$1.6M |
| Q1 2026 | -$6.2M | -$3.4M |
| Q4 2025 | -$1M | +$1.4M |
| Q3 2025 | -$1.1M | +$4.3M |
| Q2 2025 | -$5.8M | -$1.2M |
| Q1 2025 | -$2.8M | -232% |
| Q4 2024 | -$2.4M | -$168.7K |
COYA has burned cash in almost every quarter: −$22M over the past year, against −$12M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over COYA on cash generation, producing positive trailing cash flow while its opponent burns cash.
COYA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +622 shares |
| 1 year | +40% | +6.7M shares |
| 3 years | +141% | +13.7M shares |
| 5 years | +806% | +20.9M shares |
COYA has 23M diluted shares, up 40% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over COYA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
COYA Net Leverage
COYA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
COYA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 10.7 | Oversold |
COYA's weekly RSI is 37 (neutral) and its Stochastic is 11 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
COYA PE vs Healthcare Sector
COYA has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
COYA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.11 | 20% below |
| 20 week MA | $4.50 | 27% below |
| 50 week MA | $4.67 | 30% below |
| 100 week MA | $5.37 | 39% below |
| 200 week MA | $5.69 | 43% below |
COYA is in a downtrend: it's below all five of its weekly moving averages, and 43% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
COYA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $4.74 | $7.41 | +56% |
| 2024 | $7.41 | $5.92 | -20% |
| 2025 | $5.92 | $5.47 | -7.6% |
| 2026 YTD | $5.47 | $3.27 | -40% |
COYA has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.